# SELLAS Life Sciences Group, Inc. (SLS): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/sls for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling p...

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $11.49 USD |
| Market Cap | $2.32B |
| P/E (TTM) | — |
| EPS (TTM) | −$0.21 |
| 52-Week Range | $1.39 – $15.88 |
| Dividend Yield (TTM) | — |

## Dividend

SLS has no dividend payment history in our records.

## Frequently Asked Questions

### What does SELLAS Life Sciences Group, Inc. do?

SELLAS Life Sciences Group, Inc. (SLS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is SLS's market cap?

SELLAS Life Sciences Group, Inc. (SLS) has a market capitalization of approximately $2.32 billion, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does SLS pay a dividend?

No, SELLAS Life Sciences Group, Inc. (SLS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is SLS profitable?

SELLAS Life Sciences Group, Inc. (SLS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has SLS ever paid a dividend?

No. Dividend Data's records show no dividend payments from SELLAS Life Sciences Group, Inc. (SLS). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/sls
- Dividend history & safety: https://www.dividenddata.com/stocks/sls/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/sls/earnings
- Financial statements: https://www.dividenddata.com/stocks/sls/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/sls/valuation
- Peer comparison: https://www.dividenddata.com/stocks/sls/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.